These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 6413683

  • 1. I. Unbound serum gold: procedure for quantitation.
    Lorber A, Vibert GJ, Harralson AF, Simon TM.
    J Rheumatol; 1983 Aug; 10(4):563-7. PubMed ID: 6413683
    [Abstract] [Full Text] [Related]

  • 2. II. Unbound versus total serum gold concentration: pharmacological actions on cellular function.
    Lorber A, Kunishima DH, Harralson AF, Simon TM.
    J Rheumatol; 1983 Aug; 10(4):568-73. PubMed ID: 6413684
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Quantitation of gold lymphocyte binding during chrysotherapy.
    Lorber A, Wilcox S, Leeb J, Simon T.
    J Rheumatol; 1979 Aug; 6(3):270-6. PubMed ID: 114635
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Serum gold levels during chrysotherapy with relation to urinary and fecal excretion.
    Harth M.
    Clin Pharmacol Ther; 1974 Apr; 15(4):354-60. PubMed ID: 4206926
    [No Abstract] [Full Text] [Related]

  • 8. Serum gold. I. Estimation by atomic absorption spectroscopy.
    Dietz AA, Rubinstein HM.
    Ann Rheum Dis; 1973 Mar; 32(2):124-7. PubMed ID: 4632660
    [No Abstract] [Full Text] [Related]

  • 9. Terminations of treatment with gold sodium thiomalate in rheumatoid arthritis.
    Sambrook PN, Browne CD, Champion GD, Day RO, Vallance JB, Warwick N.
    J Rheumatol; 1982 Mar; 9(6):932-4. PubMed ID: 6819360
    [Abstract] [Full Text] [Related]

  • 10. [The significance of gold serum level determinations during chrysotherapy in rheumatoid arthritis (author's transl)].
    Bahous I, Müller W, Stojan B.
    Med Klin; 1975 Sep 19; 70(38):1516-21. PubMed ID: 810649
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and toxicity of retreatment with gold salts: a retrospective review of 25 cases.
    Sagransky DM, Greenwald RA.
    J Rheumatol; 1980 Sep 19; 7(4):474-8. PubMed ID: 6775078
    [Abstract] [Full Text] [Related]

  • 12. Liver toxicity profile in gold-treated Egyptian rheumatoid arthritis patients.
    Koryem HK, Taha KM, Ibrahim IK, Younes LK.
    Int J Clin Pharmacol Res; 1998 Sep 19; 18(1):31-7. PubMed ID: 9604732
    [Abstract] [Full Text] [Related]

  • 13. The influence of cigarette smoking on blood gold distribution during chrysotherapy.
    James DW, Ludvigsen NW, Cleland LG, Milazzo SC.
    J Rheumatol; 1982 Sep 19; 9(4):532-5. PubMed ID: 6813469
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Gold therapy in rheumatoid arthritis.
    Tanaka S, Ueo T, Ito T.
    Nihon Geka Hokan; 1974 Nov 01; 43(6):469-75. PubMed ID: 4218479
    [No Abstract] [Full Text] [Related]

  • 16. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report.
    Barraclough D, Brook A, Brooks P, Boyden K, Thomas D, Tymms K.
    J Rheumatol Suppl; 1982 Nov 01; 8():197-200. PubMed ID: 6813485
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Influence of gold salts treatment on the serum concentration of IL-1 and IL-2 in patients with rheumatoid arthritis.
    Lewandowicz J, Dabkowska B, Nowak D.
    Arch Immunol Ther Exp (Warsz); 1995 Nov 01; 43(3-4):195-8. PubMed ID: 8744695
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.